BRPI1013222A2 - composições de mirceno polimérico - Google Patents

composições de mirceno polimérico

Info

Publication number: BRPI1013222A2
Authority: BR; Brazil
Prior art keywords: mircene; polymeric; compositions; polymeric mircene; mircene compositions
Prior art date: 2009-03-04

Application number

BRPI1013222A

Other languages

English (en)

Inventor

Amselem Shimon

Hazan Zadik

Original Assignee

Regenera Pharma Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-03-04

Filing date

2010-03-04

Publication date

2017-09-26

2010-03-04 Application filed by Regenera Pharma Ltd filed Critical Regenera Pharma Ltd

2017-09-26 Publication of BRPI1013222A2 publication Critical patent/BRPI1013222A2/pt

2021-03-16 Publication of BRPI1013222B1 publication Critical patent/BRPI1013222B1/pt

2021-05-25 Publication of BRPI1013222B8 publication Critical patent/BRPI1013222B8/pt

Links

UAHWPYUMFXYFJY-UHFFFAOYSA-N beta-myrcene Natural products CC(C)=CCCC(=C)C=C UAHWPYUMFXYFJY-UHFFFAOYSA-N 0.000 title 1
239000000203 mixture Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/22—Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Natural Medicines & Medicinal Plants (AREA)
Microbiology (AREA)
Alternative & Traditional Medicine (AREA)
Biotechnology (AREA)
Botany (AREA)
Medical Informatics (AREA)
Epidemiology (AREA)
Mycology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Dermatology (AREA)
Diabetes (AREA)
Hematology (AREA)
Immunology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Oncology (AREA)
Pulmonology (AREA)
Obesity (AREA)
Child & Adolescent Psychology (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Communicable Diseases (AREA)

BRPI1013222A 2009-03-04 2010-03-04 composição que consiste em uma fração isolada de goma mastique obtida de pistacia lentiscus l. BRPI1013222B8 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US15721609P	2009-03-04	2009-03-04
US61/157,216		2009-03-04
PCT/IL2010/000184 WO2010100651A2 (en)	2009-03-04	2010-03-04	Compositions of polymeric myrcene

Publications (3)

Publication Number	Publication Date
BRPI1013222A2 true BRPI1013222A2 (pt)	2017-09-26
BRPI1013222B1 BRPI1013222B1 (pt)	2021-03-16
BRPI1013222B8 BRPI1013222B8 (pt)	2021-05-25

Family

ID=42536397

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI1013222A BRPI1013222B8 (pt)	2009-03-04	2010-03-04	composição que consiste em uma fração isolada de goma mastique obtida de pistacia lentiscus l.

Country Status (15)

Country	Link
US (4)	US8722105B2 (pt)
EP (2)	EP3578191A1 (pt)
CN (2)	CN102413834B (pt)
AU (1)	AU2010220057C1 (pt)
BR (1)	BRPI1013222B8 (pt)
CA (1)	CA2754565C (pt)
DK (1)	DK2403512T3 (pt)
EA (2)	EA021833B1 (pt)
ES (1)	ES2739033T3 (pt)
HK (1)	HK1218710A1 (pt)
HU (1)	HUE045444T2 (pt)
IL (2)	IL214923A (pt)
PL (1)	PL2403512T3 (pt)
TR (1)	TR201911270T4 (pt)
WO (1)	WO2010100651A2 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2010220057C1 (en)	2009-03-04	2015-10-29	Regenera Pharma Ltd.	Compositions of polymeric myrcene
PL2403505T3 (pl)	2009-03-04	2017-06-30	Regenera Pharma Ltd.	Terapeutyczne zastosowania frakcji gumy mastyksowej
AU2010310946A1 (en) *	2009-10-28	2012-05-17	Regenera Pharma Ltd.	Therapeutic uses of oligomeric and polymeric monoterpenes
KR101910781B1 (ko)	2010-09-07	2018-10-22	레제네라 파마 리미티드	매스틱 검의 산성 추출물을 포함하는 조성물
US8979797B2 (en) *	2010-12-16	2015-03-17	Ams Research Corporation	High pressure delivery system and method for treating pelvic disorder using large molecule therapeutics
WO2013011511A1 (en)	2011-07-18	2013-01-24	Mor Research Applications Ltd.	A device for adjusting the intraocular pressure
CN102526163A (zh) *	2011-12-27	2012-07-04	浙江景岳堂药业有限公司	一种用于风痛灵中乳香和没药的提取方法
WO2013186766A1 (en) *	2012-06-11	2013-12-19	Regenera Pharma Ltd.	Extracts and therapeutic uses thereof
US9458362B2 (en)	2014-04-02	2016-10-04	Kraton Polymers U.S. Llc	Adhesive compositions containing a block copolymer with polymyrcene
US10053603B2 (en)	2014-04-02	2018-08-21	Kraton Polymers U.S. Llc	Block copolymers containing a copolymer myrcene block
IL237621A0 (en) *	2015-03-08	2015-06-30	Regenera Pharma Ltd	Use of isolated fractions of the gum goddess to treat optic neuropathy
IL258279B (en) *	2015-09-24	2022-09-01	Regenera Pharma Ltd	Compositions comprising triterpenoids
HK1257370A1 (zh)	2015-09-24	2019-10-18	瑞吉纳拉制药公司	包含三萜类的组合物
US10548917B2 (en) *	2016-05-23	2020-02-04	Kaeco Group Inc.	Supplement for the prevention and treatment of gastrointestinal distress in horses and other species
US11439676B2 (en)	2018-10-16	2022-09-13	Kaeco Group, Inc.	Method for prevention or treating gastrointestinal distress in humans using mastic gum compositions
JP7012379B2 (ja) *	2016-09-08	2022-01-28	レジネラファーマリミテッド	視神経症を処置するためのトリテルペノイドを含む組成物およびその使用
WO2018047176A1 (en) *	2016-09-08	2018-03-15	Regenera Pharma Ltd.	Compositions comprising acidic extracts of mastic gum and uses thereof for treating optic neuropathy
IT201700016726A1 (it)	2017-02-15	2018-08-15	Phytoitalia Srl	Frazioni arricchite in terpeni esenti da politerpeni estratte dal mastice di chios, dispositivi cosmetici, nutraceutici e medici, e composizioni farmaceutiche che le contengono
WO2019170239A1 (en)	2018-03-08	2019-09-12	Phytoitalia Srl	Terpene enriched fractions free from polyterpenes extracted from chios mastic gum and cosmetic, nutraceutical, medical devices and pharmaceutical compositions containing them
US20210393724A1 (en) *	2018-11-01	2021-12-23	Yeditepe Universitesi	Medicine for treatment of psoriasis and production method thereof

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4374957A (en)	1981-10-29	1983-02-22	Michigan Molecular Institute	Triblock polymers of a monovinyl aromatic compound and myrcene
US4564718A (en)	1984-08-14	1986-01-14	The University Of Manchester Institute Of Science And Technology	Functionally terminated polymers from terpene monomers and their applications
US4713243A (en)	1986-06-16	1987-12-15	Johnson & Johnson Products, Inc.	Bioadhesive extruded film for intra-oral drug delivery and process
JPS63179908A (ja) *	1987-01-22	1988-07-23	Japan Synthetic Rubber Co Ltd	ミルセン重合体およびその製造方法
DE3820218A1 (de)	1988-06-14	1989-12-28	Osama L M Dr Med Dr Rer N Omer	Phytotherapeutikum zur behandlung von depressivem syndrom
US8178516B2 (en)	1992-06-30	2012-05-15	Sylvan Labs, LLC	Compositions and method for treatment of chronic inflammatory diseases
US5506406A (en)	1993-05-17	1996-04-09	Atomic Energy Corporation Of South Africa Ltd.	Method and apparatus for determining the concentration of a heavy element in a rock face
US5759569A (en)	1995-01-10	1998-06-02	The Procter & Gamble Company	Biodegradable articles made from certain trans-polymers and blends thereof with other biodegradable components
US5714007A (en)	1995-06-06	1998-02-03	David Sarnoff Research Center, Inc.	Apparatus for electrostatically depositing a medicament powder upon predefined regions of a substrate
GR950100243A (el)	1995-06-28	1997-02-28	�. ��- �. �� .�.�.	Χρησιμοποιηση της φυσικης μαστιχας χιου η του εξαγομενου εξ'αυτης φυσικου μαστιχελαιου η συνθετικων παραγωγων του για την παρασεκυη οδοντοκρεμας, οδοντικου διαλυματος, αποσμητικου στοματος, αντιηλιακων, προιοντων μαλλιων, καθως και καλλυντικων προιοντων.
JPH10130254A (ja) *	1996-11-01	1998-05-19	Jumoku Seiri Kinousei Butsushitsu Gijutsu Kenkyu Kumiai	ジヒドロクマリン系化合物およびエストロゲン作用剤
DE19646392A1 (de)	1996-11-11	1998-05-14	Lohmann Therapie Syst Lts	Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
GR1003541B (el)	1999-05-11	2001-03-07		Αντιμικροβιακη και αντιμυκητιακη δραση του εξαγομενου απο τα κλαδια, φυλλα και καρπο της μαστιχας χιου -pistacia lentiscus var chia-, μαστιχελαιου, για χρηση σε καλλυντικες, φαρμακευτικες και παραφαρμακευτικεσς εφαρμογες καθως και στην παραγωγη οδοντοτσι
GR1003550B (el)	1999-09-22	2001-03-13		Σταθερο παρασκευασμα ισοεξυλοναφθαζαρινων με πεντα- και τετρα-κυκλικα τριτερπενια, συστατικα φυτικων ελαιορητινων και κομμεων
US6623728B2 (en)	2000-06-30	2003-09-23	Unilever Home & Personal Care Usa Division Of Conopco, Inc.	Cosmetic skin care compositions and containing gum mastic
US7056491B2 (en)	2000-11-08	2006-06-06	Wisconsin Alumni Research Foundation	Monoterpenes and sesquiterpenes as chemotherapeutic and radiation sensitizers and immunomodulators
GR1003868B (el) *	2001-02-06	2002-04-19	Lavipharm S.A.	Αξιολογηση των επουλωτικων, αντιοξειδωτικων και κυτταροστατικων ιδιοτητων της μαστιχας και των συστατικων της, και οι εφαρμογες τους
CA2437578A1 (en)	2001-02-13	2002-08-22	Rivka Cohen	Carotenoid-loaded liposomes
US6534548B1 (en)	2001-10-02	2003-03-18	Kimberly-Clark Worldwide, Inc.	Isoprenoid compositions for the inhibition of exoprotein production from gram positive bacteria
DE60329098D1 (de)	2002-05-01	2009-10-15	Lavipharm Sa	Verwendung von mastix und dessen ätherischen ölen zur verhinderung oder bekämpfung von mikrobieller infektionen
JP2004083443A (ja)	2002-08-23	2004-03-18	Hideji Watanabe	マスティックを用いた歯周病予防・治療用組成物及び歯周病予防・治療方法
EP1572752B1 (en)	2002-12-20	2014-08-13	ExxonMobil Chemical Patents Inc.	Polymerization processes
EP1572753B1 (en)	2002-12-20	2012-06-13	ExxonMobil Chemical Patents Inc.	Polymerization processes
US20050074509A1 (en)	2003-10-02	2005-04-07	Data Medica Padova S.P.A.	Cancer treatment using natural plant products or essential oils extracted from some pistacia species or components
WO2005053812A1 (en)	2003-12-08	2005-06-16	Xylon Biotechnologies Ltd.	Plant materials extraction method
JP4831488B2 (ja)	2004-03-04	2011-12-07	独立行政法人理化学研究所	アイソタクチック３，４−イソプレン系重合体
WO2005112967A2 (en) *	2004-05-19	2005-12-01	Balfour Marketing Corp.	Anticancer activity of chios mastic gum
EP1768742A4 (en)	2004-07-06	2007-10-17	Transpharma Medical Ltd	ADMINISTRATION SYSTEM FOR TRANSDERMAL IMMUNIZATION
CA2574898C (en)	2004-07-23	2011-12-20	Tsung-Chung Lin	Immune modulation and anti-allergy activities of zingiber zerumbet
EP1817941A4 (en)	2004-11-13	2009-11-11	Metaproteomics Llc	CYCLOOXYGENASE-2 INHIBITION COMPOSITIONS
US20070036873A1 (en)	2005-07-27	2007-02-15	Shibnath Ghosal	Method of treatment or management of stress
US20070148187A1 (en)	2005-12-27	2007-06-28	Intact Enterprises, Inc.	Mastic gum composition for use as a dietary supplement in humans and animals
AR060847A1 (es)	2007-05-03	2008-07-16	Spannagel Lucia Antonia	Formulacion a base de calendula, aloe y centella.
PL2403505T3 (pl) *	2009-03-04	2017-06-30	Regenera Pharma Ltd.	Terapeutyczne zastosowania frakcji gumy mastyksowej
AU2010220057C1 (en)	2009-03-04	2015-10-29	Regenera Pharma Ltd.	Compositions of polymeric myrcene

2010
- 2010-03-04 AU AU2010220057A patent/AU2010220057C1/en not_active Ceased
- 2010-03-04 DK DK10710912.6T patent/DK2403512T3/da active
- 2010-03-04 WO PCT/IL2010/000184 patent/WO2010100651A2/en not_active Ceased
- 2010-03-04 CN CN201080018570.3A patent/CN102413834B/zh not_active Expired - Fee Related
- 2010-03-04 EA EA201190170A patent/EA021833B1/ru not_active IP Right Cessation
- 2010-03-04 BR BRPI1013222A patent/BRPI1013222B8/pt not_active IP Right Cessation
- 2010-03-04 TR TR2019/11270T patent/TR201911270T4/tr unknown
- 2010-03-04 EA EA201492273A patent/EA201492273A1/ru unknown
- 2010-03-04 US US13/254,380 patent/US8722105B2/en active Active
- 2010-03-04 EP EP19158751.8A patent/EP3578191A1/en active Pending
- 2010-03-04 PL PL10710912T patent/PL2403512T3/pl unknown
- 2010-03-04 CA CA2754565A patent/CA2754565C/en active Active
- 2010-03-04 CN CN201510616984.0A patent/CN105147759A/zh active Pending
- 2010-03-04 ES ES10710912T patent/ES2739033T3/es active Active
- 2010-03-04 EP EP10710912.6A patent/EP2403512B1/en active Active
- 2010-03-04 HU HUE10710912A patent/HUE045444T2/hu unknown
2011
- 2011-09-01 IL IL214923A patent/IL214923A/en active IP Right Grant
2014
- 2014-03-26 US US14/226,293 patent/US9655938B2/en not_active Expired - Fee Related
2016
- 2016-06-10 HK HK16106667.1A patent/HK1218710A1/zh unknown
- 2016-09-26 IL IL248056A patent/IL248056B/en active IP Right Grant
2017
- 2017-04-13 US US15/486,964 patent/US10307449B2/en active Active
2019
- 2019-04-23 US US16/391,881 patent/US10806763B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US9655938B2 (en)	2017-05-23
EP2403512A2 (en)	2012-01-11
US10307449B2 (en)	2019-06-04
IL248056B (en)	2019-07-31
US20120039992A1 (en)	2012-02-16
AU2010220057A1 (en)	2011-10-13
US20170252387A1 (en)	2017-09-07
US20190255132A1 (en)	2019-08-22
IL214923A (en)	2016-10-31
WO2010100651A4 (en)	2010-12-23
PL2403512T3 (pl)	2019-10-31
EP2403512B1 (en)	2019-05-15
WO2010100651A3 (en)	2010-10-28
CA2754565C (en)	2020-12-29
US10806763B2 (en)	2020-10-20
DK2403512T3 (da)	2019-07-22
HUE045444T2 (hu)	2019-12-30
BRPI1013222B8 (pt)	2021-05-25
US20140294928A1 (en)	2014-10-02
EA201190170A1 (ru)	2013-01-30
AU2010220057C1 (en)	2015-10-29
CA2754565A1 (en)	2010-09-10
AU2010220057B2 (en)	2015-04-02
EP3578191A1 (en)	2019-12-11
HK1218710A1 (zh)	2017-03-10
ES2739033T3 (es)	2020-01-28
IL248056A0 (en)	2016-11-30
BRPI1013222B1 (pt)	2021-03-16
CN102413834A (zh)	2012-04-11
US8722105B2 (en)	2014-05-13
CN105147759A (zh)	2015-12-16
EA201492273A1 (ru)	2015-04-30
WO2010100651A2 (en)	2010-09-10
CN102413834B (zh)	2016-11-09
TR201911270T4 (tr)	2019-08-21
IL214923A0 (en)	2011-11-30
EA021833B1 (ru)	2015-09-30

Legal Events

Date	Code	Title	Description
2017-12-12	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]	Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.
2018-04-17	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2018-06-12	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-06-26	B07B	Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette]
2018-07-03	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
2018-09-18	B06T	Formal requirements before examination [chapter 6.20 patent gazette]
2019-07-23	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2020-04-28	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2020-08-25	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2021-01-05	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2021-03-16	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 16/03/2021, OBSERVADAS AS CONDICOES LEGAIS.
2021-05-25	B16C	Correction of notification of the grant [chapter 16.3 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 04/03/2010 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF
2023-12-26	B21F	Lapse acc. art. 78, item iv - on non-payment of the annual fees in time	Free format text: REFERENTE A 14A ANUIDADE.
2024-04-16	B24J	Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)	Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2764 DE 26-12-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

Publication	Publication Date	Title
BRPI1013222A2 (pt)	2017-09-26	composições de mirceno polimérico
EP2473555A4 (en)	2014-10-08	POLYMER COMPOSITIONS
SMT201600307B (it)	2016-11-10	Composizione liposomiale
DK3078664T3 (da)	2019-05-13	Antiparasitiske dihydroazol-sammensætninger
EP2488022A4 (en)	2014-02-19	Compositions
EP2502962A4 (en)	2014-04-30	Resin composition
UY33161A (es)	2011-07-29	Composiciones plaguicidas
BRPI1013588A2 (pt)	2016-04-19	composição
EP2381760A4 (en)	2013-01-16	CORN PROTEIN COMPOSITION
DK2634231T3 (da)	2022-09-19	Sammensætninger
BRPI1015474A2 (pt)	2016-04-26	composição
IT1400743B1 (it)	2013-07-02	Composizioni polimeriche
BRPI1010690A2 (pt)	2016-03-15	composições
DOP2011000396A (es)	2012-02-15	Composiciones novedosas
BRPI1005525A2 (pt)	2016-02-23	compostos de azaazuleno
BR112012001930A2 (pt)	2016-03-15	composição termoplástica
BR112012001747A2 (pt)	2016-04-12	composição termoplástica
EP2459663A4 (en)	2014-01-01	COATING COMPOSITIONS
BR112012015256A2 (pt)	2016-03-15	composição termoplastica
BRPI1013275A2 (pt)	2016-07-26	composições de cobre-carbono
EP2624836A4 (en)	2014-05-14	BEPOTASTIN COMPOSITION
FR2947857B1 (fr)	2012-03-30	Agencement de deshuileur
EP2479211A4 (en)	2013-06-05	FLUOR RUBBER COMPOSITION
BRPI1007245A2 (pt)	2016-10-18	composição polimérica
BRPI1010198A2 (pt)	2016-03-29	composição de poliamida modificada